Lindy Biosciences, Inc.

About

Lindy Biosciences, Inc. is a biotechnology company based in Morrisville, North Carolina, founded in 2017. The company specializes in developing innovative protein therapeutic formulations aimed at enhancing drug delivery for biologics, particularly high-concentration monoclonal antibodies. Lindy has created the Microglassification™ technology, which transforms protein solutions into stable, dense microbeads suitable for long-term storage and advanced formulations. The Microglassification™ platform produces dry protein particles that facilitate high-concentration biologics suspensions, allowing for subcutaneous self-administration in small volumes. This technology improves stability and reduces viscosity compared to traditional liquid solutions, making it easier for patients to manage their treatments at home. Lindy collaborates with pharmaceutical companies to integrate its technology into drug development pipelines, offering formulation development services and expertise in biotherapeutics. The company is actively working with several leading global pharmaceutical firms to advance biotherapeutic programs.